Showing results (711-720 of 729) with videos related to

Sort By:
Pageof 73
Circulation Research|March 3, 2025
Intestinal Microbiota Contributes to the Development of Cardiovascular Inflammation and Vasculitis in MicePrasant K Jena, Daiko Wakita, Angela C Gomez, et al.
ESMO Open|August 3, 2023
Inequality factors in access to early-phase clinical trials in oncology in France: results of the EGALICAN-2 studyE Charton, C Baldini, Y Fayet, et al.
Cells|December 9, 2023
Hypoxia Induces Alterations in the Circadian Rhythm in Patients with Chronic Respiratory DiseasesManuel Castillejos-López, Yair Romero, Angelica Varela-Ordoñez, et al.
Annals of the American Thoracic Society|May 18, 2021
The Role of Surgical Lung Biopsy in the Diagnosis of Fibrotic Interstitial Lung Disease: Perspective from the Pulmonary Fibrosis FoundationLida P Hariri, Anja C Roden, Jonathan H Chung, et al.
Medrxiv : the Preprint Server for Health Sciences|April 2, 2024
Recessive variants in the intergenic NOS1AP-C1orf226 locus cause monogenic kidney disease responsive to anti-proteinuric treatmentFlorian Buerger, Daanya Salmanullah, Lorrin Liang, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|May 20, 2017
Biomarkers of exposure to new and emerging tobacco delivery productsSuzaynn F Schick, Benjamin C Blount, Peyton Jacob, et al.
Contraception|January 1, 1979
Rate of metabolism of norethisterone in women from different populationsK Fotherby, K Shrimanker, H A Abdel-Rahman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2024
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE studyF Lordick, M E Mauer, G Stocker, et al.
Clinical Epigenetics|January 8, 2021
DNA methylation and lipid metabolism: an EWAS of 226 metabolic measuresMonica Del C Gomez-Alonso, Anja Kretschmer, Rory Wilson, et al.
Haematologica|January 18, 2015
Ofatumumab in poor-prognosis chronic lymphocytic leukemia: a phase IV, non-interventional, observational study from the European Research Initiative on Chronic Lymphocytic LeukemiaCarol Moreno, Marco Montillo, Panayiotis Panayiotidis, et al.
Pageof 73